West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 853,900 | 894,300 | 762,600 | 615,500 | 439,100 |
| Receivables | 512,000 | 507,400 | 489,000 | 385,300 | 319,300 |
| Inventories | 434,700 | 414,800 | 378,400 | 321,300 | 235,700 |
| Other current assets | 135,800 | 103,000 | 112,000 | 51,600 | 64,600 |
| TOTAL | $1,936,400 | $1,919,500 | $1,742,000 | $1,373,700 | $1,058,700 |
| Non-Current Assets | |||||
| PPE Net | 1,413,300 | 1,158,300 | 1,057,500 | 943,200 | 839,300 |
| Investments And Advances | 210,000 | 204,900 | 207,700 | 214,700 | 192,700 |
| Intangibles | 123,600 | 125,700 | 132,900 | 141,600 | 137,600 |
| Other Non-Current Assets | 146,200 | 208,400 | 173,700 | 120,600 | 113,100 |
| TOTAL | $1,893,100 | $1,697,300 | $1,571,800 | $1,420,100 | $1,282,700 |
| Total Assets | $3,829,500 | $3,616,800 | $3,313,800 | $2,793,800 | $2,341,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 242,400 | 215,400 | 232,200 | 213,100 | 156,800 |
| Accrued Expenses | 122,500 | 101,600 | 116,300 | 132,000 | 73,000 |
| Other current liabilities | 155,200 | 183,800 | 165,800 | 145,900 | 93,500 |
| TOTAL | $671,800 | $519,000 | $594,100 | $503,400 | $341,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,800 | 206,700 | 208,800 | 252,900 | 255,000 |
| Other Non-Current Liabilities | 172,600 | 172,800 | 141,700 | 149,700 | 138,300 |
| TOTAL | $276,700 | $412,900 | $384,300 | $435,900 | $426,600 |
| Total Liabilities | $948,500 | $931,900 | $978,400 | $939,300 | $768,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,299 | 74,136 | 74,282 | 74,103 | 73,837 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 3,523,400 | 2,987,800 | 2,456,700 | 1,846,700 | 1,549,400 |
| Other shareholders' equity | -143,400 | -182,900 | -159,100 | -110,300 | -149,700 |
| TOTAL | $2,881,000 | $2,684,900 | $2,335,400 | $1,854,500 | $1,573,200 |
| Total Liabilities And Equity | $3,829,500 | $3,616,800 | $3,313,800 | $2,793,800 | $2,341,400 |